Vancouver 2006 Program

June 28 - July 1, 2006
Individual abstracts are available for viewing/download by clicking on the nominees name.

Wednesday - Arrival
  1900 Reception


Thursday - Scientific Sessions
  0830 - 1000 I  Challenge of Glaucoma in the Developing World
Co-Chairs: Sommer, Resnikoff

Sommer: Introduction and background
Resnikoff (WHO): The Major Causes of Blindness in the World
Quigley: Prevalence and burden of glaucoma
Robin: Access to care-availability and costs of surgical and medical treatments, and patient compliance
Friedman: A “modest proposal” for WHO guidelines and recommendations for the prevention and treatment of glaucoma

  1000 - 1030 Break
  1030 - 1200

II  Epidemiology of world wide glaucoma
Co-Chairs: Wormald, Quigley (Pre-circulated material)
Please use the user name and password which were sent to you in the last 48 hours by Rich Parish
In this session, the presentations will be brief and the discussion will be very interactive.

    Open Angle Glaucoma
Organization of care in 3 settings:
highly developed countries
most dis-advantaged countries
    Angle Closure Glaucoma
The need to develop evidence on which we can base whom to treat with iridotomy and other therapy
  1200 - 1330 Lunch
  1330 - 1500

III  Identification and screening
Co-Chairs: Weinreb, Seah

    Screening For Open Angle Glaucoma
Wilson: Background
    Is screening Feasible for Open Angle Glaucoma?
Coleman: IOP and Risk Analysis
Heijl: Visual Fields
Zangwill: Imaging
Lee - Yes
Hitchings No
    Is Screening Feasible for Angle Closure Glaucoma?
Friedman: Conventional Approaches
Aung: New screening modalities
Foster - Yes
Thomas - No
  1530 - 1700 IV  Presentations by Society nominees
5 presentations - each 11 minutes with 7 minute discussion
  1530 - 1541 Edward: Clinical Course of Bimatoprost-Induced Periocular Skin Changes in Caucasia
  1548 - 1559 Garudadri: Effect of optic disc size on the diagnostic capability of the imaging technologies in glaucoma
  1606 - 1617 Johnson, C: Normal Age-Related Sensitivity for a Variety of Visual Functions Throughout the Visual Field
  1624 - 1635 Johnson, D: Prostaglandins increase outflow facility in cultured human anterior segments
  1642 - 1653 Kee: Injection of Cultured Autologous Fibroblasts into the Subconjunctival Space of Rabbits Treated with Mitomycin C


Friday - Scientific Sessions
  0800 - 1000 V - Basic Science considerations
Co-Chairs: Chauhan, Tamm

Burgoyne: What really defines glaucomatous Cupping
Epstein: A New Hypothesis about Glaucoma
Weinreb: The Mouse in Glaucoma Research
Chauhan: Endothelin and experimental optic nerve damage
O’Brien: Gene Expression Studies in Optic Nerve Cells in Glaucoma
Tamm: Bone Morphogenetic Protein 7 is an Endogenous Antagonist of Transforming Growth Factor 2 in Trabecular Meshwork Cells and Tenon’s Fibroblasts
Kaufman: Caldesmon – A New Target for Gene Therapy in Glaucoma

  1000 - 1030 Break
  1030 - 1200 VI - Presentations by Society nominees
5 presentations - each 11 minutes with 7 minute discussion
  1030 - 1041 Kwon: Automatic cup-to-disc segmentation from stereo color fundus photographs using pixel feature classification algorithm
  1048 - 1059 Mills: The AGS Patient Care Improvement Project
  1106 - 1117 Nicolela: Prospective longitudinal study in glaucoma patients with specific optic disc phenotypes: Baseline characteristics and endothelin-1 related vascular reactivity
  1124 - 1135 Richards: Expression Profile Approach to Glaucoma Gene Detection
  1142 - 1153 Robin: Anecortave Acetate: Both a Novel Agent and Novel Delivery
System: Pilot Studies in Glaucoma
  1200 - 1400 Luncheon and Business meeting
  1400 - 1430 GOLDMANN LECTURE: The Glaucoma Graph
Professor Roger Hitchings
  1430 - 1500 Break
  1500 - 1700 VII - Pharmacologic treatment worldwide issues
Co-Chairs: Podos, Kaufman
Guest Panelist: Stephen Drance

Lee: Need - Epidemiologic, Demographic and Geographic Considerations
Robin: Availability: Getting Therapies to Those Who Need It
Coleman: Cost - To Patients, Countries and Society
Who Manufactures and Pays - Industry’s Role
Scott Whitcup, Kevin Buehler, Jack McMillan
Wilson: Pharmacogenetics and Ethnicity
Epstein: The Role of Scientific Discovery
Tuulonen: The Role of the Internet and Telemedicine


Saturday - Scientific Sessions
  0800 - 1000 VIII - Improving Surgical Care throughout the World
Co-Chairs: Khaw, Grehn

Grehn: Surgical Approaches to Childhood Glaucoma Around the World
Khaw: Should Anti-Scarring Therapies be Used in Every Glaucoma Surgery Performed Around the World
Quigley: Rational Approach to Glaucoma Surgery in Africa
Gandolfi: Is Non Penetrating Surgery Realistic for the Worldwide Surgical Treatment of Glaucoma?
Minckler: Devices – Are These a Realistic Approach to Surgery Around the World?
Aung: Surgical Approaches to Angle Closure Glaucoma

  1000 - 1030 Break
  1030 - 1130 IX - Presentations by Society nominees
4 presentations – each 10 minutes with 5 minute discussion
  1030 - 1040 Schuman: High-Speed, Ultra-High Resolution Optical Coherence Tomography in Glaucoma
  1045 - 1055 Sugiyama: Circadian intraocular pressure rhythm is generated by clock genes
  1100 - 1110 Yu: Pathways And Mechanisms Of Glaucoma Micro Drainage Surgery
  1115 - 1120 Jampel: Depression and mood indicators in newly diagnosed glaucoma patients
  1130 - 1300 X - Defining Progression in glaucoma
Are uniform worldwide standards possible?
Co-Chairs: Anderson, Garway-Heath
    Sekhar: Present Methods Used Clinically for Monitoring Glaucoma in the Parts of the World Familiar to me.
Drance: Present Methods Used Clinically for Monitoring Glaucoma in the Parts of the World Familiar to me.
Heijl: Obstacles to use of Visual Field Testing for Monitoring Progression
Chauhan: Obstacles to use Optic Disc Appearance to Monitor Progression
Caprioli: Potential for new Technologies for Monitoring Glaucoma in Various Clinical and Research Settings
Panel Discussion (30min): Speakers and other Society Members


Saturday - Social Program
  1330 - 1600 Boat Cruise